AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026Net selling: insiders sold $3.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$3.3M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 26- Open
- $308.24
- 52-wk high
- $341.06
- High
- $312.30
- 52-wk low
- $242.07
- Low
- $306.55
- Prev close
- $308.95
- Mkt cap
- $25.11B
- P/E
- 25.6x
- Volume
- 821.5K
- Fwd P/E
- 16.2x
- Beta
- 0.85
- Div yield
- 0.93%
- P/S
- 1.8x
- P/B
- 2.9x
- Profit margin
- +7.0%
- Op margin
- +12.2%
- ROE
- +11.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about LH filings
Are insiders buying or selling Laboratory Corporation of America Holdings (LH) stock?
Net selling: insiders sold $3.3M and bought $0 of LH stock on the open market in the 90 days to Sep 27, 2026, according to SEC Form 4 filings. $2.5M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Schechter, Adam H (President & CEO), who sold $1.5M. The latest filing was on Aug 18, 2026.
Which members of Congress have traded LH recently?
None. No member of Congress disclosed a LH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this LH smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- SQ
Squarepoint
$35.0M
added
- MI
Millennium
$30.6M
added
Sells/Trims (1)
- GA
Gotham Asset
$23.2M
trimmed
What insiders are doing
What Congress is doing
How top traders are positioned
No tracked top-trader positions in LH right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 4.2% above what analysts expected.
Earnings per share
$4.79 expected
Revenue
No comparable estimate
Reports Oct 27, 2026, in 30 days
Estimates as of Sep 27, 2026
EPS expected
$4.49 to $4.73
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.56B | $3.52B | $3.54B | $3.73B |
| Cost of what it sold | $2.54B | $2.60B | $2.60B | $2.62B |
| Gross profit | $1.03B | $920.6M | $938.2M | $1.11B |
| What it spent | ||||
| Sales and admin | $552.4M | $538.6M | $551.0M | $577.2M |
| Other operating costs | $76.1M | — | — | $83.2M |
| Total operating expenses | $628.5M | $538.6M | $551.0M | $660.4M |
| What was left | ||||
| Operating profit | $396.6M | $382.0M | $387.2M | $451.6M |
| Interest on debt | $56.0M | $55.0M | $55.1M | $61.1M |
| Profit before tax | $337.0M | $190.6M | $319.7M | $386.4M |
| Tax | $75.5M | $25.7M | $41.7M | $87.3M |
| Net profit | $261.1M | $164.7M | $277.8M | $298.7M |
| EBITDA | $564.0M | $418.6M | $548.1M | $620.9M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Tone of tracked coverage
Labcorp Reaffirms Long-Term Earnings Outlook
BullishSep 24Pediatrix Medical Group, Inc. (MD) Stock Price, News, Quote & History
NeutralSep 23Charles River Labs stock rises 2.19 percent ahead of the open
Leans bearishSep 23Labcorp reaffirms long-term outlook despite preliminary CMS payment cuts
NeutralSep 22Labcorp stock falls as CMS proposes 15 percent reimbursement cuts
BearishSep 22Why Labcorp Holdings Stock Dropped Today
Leans bearishSep 22Perspective: First-Void Urine - A New Era in Accessible STI Testing
Leans bullishSep 22Is Quest Diagnostics Stock Outperforming the Nasdaq?
Leans bearishSep 22
Macro
20 macro signals shaping LH right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results